Overview
Pharmagene Discovery Services is a contract research organisation specializing in human tissue-based drug discovery and preclinical research. Operating since 1996 from Cambridge, UK, the company provides customized assay development, spatial biology analysis, target validation, biomarker discovery, and biotherapeutic safety testing using consented human biospecimens. Their services support pharmaceutical, biotechnology, and patient foundation clients throughout the drug discovery and development pipeline.
Frequently asked questions
- What are Pharmagene's core service offerings?
- Pharmagene provides human tissue-based assays, spatial biology interrogation, functional cellular biology studies, bioassays, target expression analysis, disease characterization, therapeutic target validation, biomarker discovery, and biotherapeutic safety testing in human tissues and primary human cells.
- What regulatory standards and certifications does Pharmagene maintain?
- Pharmagene operates to GLP (Good Laboratory Practice) standards and is licensed by the UK Human Tissue Authority, ensuring compliance with regulatory requirements for human tissue research.
- Does Pharmagene maintain tissue samples and biospecimens?
- Yes, Pharmagene has created and curates an in-house human tissue biorepository to support client research. The company also offers sample processing and biostorage services to support ongoing studies.
- How does Pharmagene reduce reliance on animal testing?
- Pharmagene specializes in designing and implementing innovative in vitro models and tissue-based platforms using human biospecimens, enabling researchers to generate human-relevant data while reducing dependence on animal testing.
- What types of organizations does Pharmagene partner with?
- Pharmagene partners with global life science organizations including biopharmaceutical companies, biotechnology firms, and patient foundations, providing customized discovery and preclinical research services.